School of Medicine
Showing 1,051-1,100 of 12,892 Results
-
Nathaniel Aidan Blecher
Clinical Assistant Professor, Ophthalmology
BioDr. Nathaniel Blecher is a board-certified, fellowship-trained ophthalmologist who specializes in glaucoma care at Stanford Health Care. He is also a clinical assistant professor in the Department of Ophthalmology at Stanford University School of Medicine.
His clinical interests include innovative surgical treatments for glaucoma—including minimally invasive glaucoma surgery (MIGS)—as well as the connection between lifestyle and ocular health. Dr. Blecher provides comprehensive care for the full spectrum of glaucoma, both early-stage and particularly advanced disease.
His individualized approach includes laser therapy, medical management, MIGS procedures, and more complex interventions such as tube shunt placement and trabeculectomy. He also treats coexisting conditions like cataracts, ensuring patients receive coordinated, whole-eye care.
Dr. Blecher’s research interests include treatments for pseudophakic angle closure, which is a rare situation when high pressure inside the eye suddenly develops despite cataract surgery. He has also studied the finer details of correctly detecting glaucoma progression based on optical coherence tomography (OCT) analysis, considering the changes that can be seen from comorbid conditions such as hypertension and diabetes.
Dr. Blecher’s research has been published in leading peer-reviewed journals, including Ophthalmology, Ophthalmic Plastic & Reconstructive Surgery, and Ophthalmology Case Reports. He has presented internationally on topics such as MIGS and complex glaucoma management.
He is a member of the American Academy of Ophthalmology and the American Glaucoma Society. -
Nikolas Blevins, MD
Larry and Sharon Malcolmson Professor in the School of Medicine, Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsInner ear microendoscopy -- Developing techniques for minimally-invasive imaging of inner ear microanatomy and neural pysiology. Applications include improved cochlear implant development, inner ear regenerative techniques, inner ear surgery, and auditory physiology.
Microsurgical robotics -- Developing scalable microsurgical instrumentation and robotic techniques for use in head and neck surgery.
Surgical Simulation -- Immersive environment for temporal bone surgical simulation. -
Catherine Blish
George E. and Lucy Becker Professor in Medicine
Current Research and Scholarly InterestsThe major goal of our research is to gain insight into the prevention and control of HIV and other viral pathogens by studying the interplay between the virus and the host immune response. We investigate the role of various arms of the immune response, but with a particular focus on NK cells. We hope to gain additional insights into control of infectious diseases by studying how pregnancy modulates immune responses.
-
Daniel Bloch
Professor (Research) of Biomedical Data Science (BDS), Emeritus
BioI received my PhD. in Mathematical Statistics in 1967. I joined the research community at the Stanford University School of Medicine, Division of Immunology & Rheumatology, in 1984 as head statistician directing the biostatistics consulting and analytic support of the Arthritis Rheumatism Aging Medical Information System (ARAMIS) and Multipurpose Arthritis Center (MAC) grant-related research programs. In 1993 I was appointed Associate Professor with a joint appointment in the Departments of Medicine and of Health Research & Policy, and am currently Professor of Biostatistics at Stanford University, emeritus since 2007. My contributions to the statistics literature span numerous fields, including methods of sample size estimation, efficiency and bias of estimators, research methods for kappa statistics, non-parametric classification methods and methods of assessing multi-parameter endpoints. I have over 200 peer-reviewed publications. I have been directly involved with the development of numerous criteria rules for classification of diseases and with establishing guidelines for clinical trial research and in proposing responder criteria for osteoarthritis drugs. Since 1987, I have been a consultant on an ad hoc basis to pharmaceutical and biotechnical firms, including both start-up and established companies. I have extensive experience with devices, drugs and biologics and have participated in all aspects of applying statistics to implement investigational plans; e.g.: for protocol development, design of trials, database design. I’ve been a member of the FDA Statistical Advisors Panel, the statistical member on numerous data safety monitoring boards, and frequently represent companies at meetings with the FDA
-
Barbara Block
Charles and Elizabeth Prothro Professor of Marine Sciences, Professor of Oceans and Senior Fellow at the Woods Institute for the Environment
Current Research and Scholarly InterestsThermal physiology, open ocean predators, ecological physiology and tuna biology
-
Andra Leah Blomkalns
Redlich Family Professor
Current Research and Scholarly InterestsDr. Andra Blomkalns is an innovation advocate who believes the best patient-centered programs depend upon clinical practice innovation, continuous data-driven improvement, and interdisciplinary collaboration. Dr. Blomkalns has a long-standing history of scholarship and publication on cardiovascular emergencies, point-of-care testing, innate immunity, and obesity. She has authored or contributed to more than 14 chapters and more than 40 journal articles in peer-reviewed publications on topics influential to administration and organization, clinical best practices, and scientific exploration. Additionally, her grant portfolio diversity reflects her multi-pronged, collaborative approach, and includes institutional, investigator-initiated industry, and federal funding.
-
Daniel Michael Blonigen
Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Blonigen is a Research Career Scientist and an Associate Director at the Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System. He is also an Affiliate Investigator with the VA National Center for Homelessness Among Veterans, and an Associate Professor in the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine. He received his doctorate in clinical psychology from the University of Minnesota and is a former VA Career Development Awardee. He is licensed as a clinical psychologist in the State of California.
Dr. Blonigen’s research mission is to identify and develop innovations to increase access and engagement in substance use and mental health care for vulnerable populations. In particular, he is interested in testing the effectiveness and implementation potential of mobile health and peer-based interventions for justice-involved and homeless veterans. He is currently leading or co-leading multisite trials of behavioral interventions for justice-involved and homeless veterans. He is also funded by VA Health Systems Research to tailor smartphone applications for self-management of unhealthy drinking for veteran primary care patients and use of peer specialists to increase patient engagement with these apps.
In addition to research, Dr. Blonigen is actively involved in mentoring and teaching VA research fellows and Stanford University residents. These roles include serving as a faculty mentor for the Stanford Forensic Psychiatry Fellowship Program and the Ci2i VA Palo Alto Training Program. He is a member of several VA management and oversight committees and has served as a grant reviewer for national and international funders. He is an invited speaker at national conferences and cyberseminars devoted to substance use and mental health research, and he holds editorial positions for leading addiction, personality, and assessment journals. -
Gordon Bloom
Lecturer, Medicine - Primary Care and Population Health
BioGordon founded the Social Entrepreneurship Collaboratory (SE Labs) at Stanford, Harvard and Princeton. He teaches about the design, development and leadership of innovative social impact ventures in global health and environmental sustainability.
At Stanford, Gordon is director of the Social Entrepreneurship and Innovation Lab (SE Lab)- Human & Planetary Health and is a faculty fellow of the Center for Innovation in Global Health. He is a Lecturer in the School of Medicine, Division of Primary Care and Population Health/Dept. of Medicine, and an advisor in the Distinguished Careers Institute (DCI), and the Knight-Hennessy Scholars Program, and cofounder of the Stanford Sustainable Societies Lab.
At Harvard, Gordon taught jointly on the faculties of the Harvard T. H. Chan School of Public Health (Health Policy & Management) and the Harvard Kennedy School (Management, Leadership & Decision Sciences) and served as an Expert-in-Residence (EiR) at the Harvard Innovation Lab (i-Lab), and affiliated faculty at the Center for Primary Care, Harvard Medical School (HMS). He was faculty director of the Social Entrepreneurship and Innovation Lab (SE Lab) for US & Global Health, an incubator course taught in a new interdisciplinary, collaborative model based at the i-Lab. He has also served as an Entrepreneur-in-Residence (2013-2014) at Harvard Business School in the Rock Center for Entrepreneurship, on the Faculty of Arts & Sciences in the Sociology Department, at the Harvard Kennedy School, on the Leadership & Management faculty, and as a principal of the Hauser Center for Non-Profit Organizations (2004-2007). Gordon served as one of the founding faculty of the $10 million Reynolds Fellows Program in Social Entrepreneurship, a Center for Public Leadership and Harvard President’s interdisciplinary fellowship initiative that paid full tuition and stipend for graduate students from the Harvard Kennedy School, School of Public Health and Graduate School of Education.
At Princeton, Gordon served as Dean’s Visiting Professor in Entrepreneurship in 2009-2010. Working together with the School of Engineering & Applied Science, the [Woodrow Wilson] School of Public & International Affairs, and the Faculty of Arts & Sciences, he launched a new set of programs and prizes in social innovation and entrepreneurship in collaboration with students, faculty and alumni.
At Stanford in 2001-2002, Gordon created the SE Lab, a Silicon Valley and technology–influenced, interdisciplinary incubator for social impact ventures and global problem solving. Gordon taught on the Public Policy Program and Urban Studies Program faculties (School of Humanities & Sciences) and served as a faculty affiliate at the Center for Social Innovation at Stanford Graduate School of Business, and a Program Officer at Stanford’s Freeman Spogli Institute for International Studies.
Many of the talented students and fellows in Gordon’s SE Labs have won the top awards of prestigious idea and business plan competitions, including those at Stanford, Harvard, Princeton and MIT.
Gordon is a co-author in the edited volume Frontiers in Social Innovation (N. Malhotra, ed., Harvard Business Review Press, 2022) and Social Entrepreneurship: New Models of Sustainable Social Change (A. Nicholls, ed., Oxford University Press, 2006/2008) and served as a founding member of the Oxford/Ashoka led University Network for Social Entrepreneurship. His interest in entrepreneurship is informed by work in both the private and nonprofit sectors in the U.S. (New York, Cambridge, Palo Alto), Europe (London, Paris) and Asia (Hong Kong), as CEO of a medical technology company (EDAP Technomed, USA) and in international strategy consulting (Bain & Co. Ltd.).
Gordon is married to Sara Singer- they on occasion teach together at Stanford, have a daughter Audrey and son Jason, and live in the Frenchman's Hill residential section of campus. -
Zaeda Blotner
Immigrant Child Health Program Administrator, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordImmigrant Child Health Program Administrator
-
Yair Blumenfeld, MD
Professor of Obstetrics and Gynecology (Maternal Fetal Medicine)
On Partial Leave from 02/15/2026 To 03/15/2026Current Research and Scholarly Interestsprenatal diagnosis, genetics, clinical obstetrics
-
Mark S. Blumenkranz, MD, MMS
H. J. Smead Professor of Ophthalmology, Emeritus
Current Research and Scholarly InterestsClinical Interest and Research
My primary areas of interest are in the diagnosis, medical and surgical treatment of vitreal retinal diseases. These principally include age-related macular degeneration and other diseases of the macula, and tractional syndromes, diabetic retinopathy, and complex forms of retinal detachment. I have been interested in the development of novel technology to diagnose and treat these diseases, including new forms of imaging, laser delivery systems, other microsurgical tools, and new drugs and drug delivery systems that inhibit new blood vessel growth, scarring and intraocular inflammation. I have been actively involved in translational research in the laboratory as well as technology transfer associated with that research for a variety of new therapies that have received FDA clearance and been introduced into clinical practice over the past 30 years.
Administrative and Community Service
I have served on the Board of Directors of a variety of voluntary education and service organizations, including the Corporation of Brown University, multiple scientific advisory boards and various philanthropic and research organizations. -
Paul D. Blumenthal, MD, MPH
Professor of Obstetrics and Gynecology (Gynecology-Family Planning) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsImproving Access to Family Planning Services in Low Resource Settings:
Through a collaboration with Population Services International, the Stanford Program for International Reproductive Education and Services (SPIRES) provides technical direction in a program designed to improve access to and uptake of family planning, particularly Long Acting Reversible Contraception (LARC) such as IUDs and implants, in 14 developing countries globally. The first year saw insertion of over 280,000 IUDs. -
Fernando E Boada
Professor of Radiology (Radiological Sciences Laboratory)
BioFernando Boada is a Professor of Radiology and Associate Chair for Basic Science Translational Research at Stanford University Medical School. [1] He joined Stanford in 2021 after being Professor of Radiology, Psychiatry and Neurosurgery at New York University Medical School and the Director of the Center for Advanced Imaging Innovation and Research. [1] Prior to joining NYU in 2012, Dr. Boada directed the MR Research Center (MRRC) at the University of Pittsburgh for ten years. [1] His research efforts have been focused on the development of novel MRI techniques for addressing open neuroimaging questions in a translational setting.
-
Christina Bodurow
Affiliate, Medicine - Med/Gastroenterology and Hepatology
BioChris has a proven record of accomplishment delivering results to pharmaceutical and scientific organizations, including 33 years of management experience at Eli Lilly and Company, within Lilly Research Laboratories (LRL), 3.5 years in a global leadership role at IQVIA, and now as Deputy Director and COO of a significant NIH/NIAID research grant at Stanford University Medical School.
Over the years, Chris has served as a leader of multiple global teams in drug development and R&D Operations, representing her organizations in multiple external settings, including scientific, academic, drug development and R&D Operations forums.
In, December 2017, Chris retired from Lilly as Sr. Director, External Sourcing, leading an enterprise-wide R&D operations group that partnered with LRL functions to assess, on-board, and govern third party organizations across the entire drug development value chain, from pre-clinical, through clinical, regulatory, safety, health outcomes, product and device development, and diagnostics. The division consolidated both corporate and external requirements to deliver high-quality, risk-based, third party governance, oversight and alliance management for the LRL Development organization.
In February 2019, Chris joined IQVIA as the Vice-President of Strategy & Operations for DSSR, and subsequently moved in the role of Vice-President, Global Regulatory Affairs.
Specialties: Pharmaceutical Development, R&D Operations, Molecule Submission/Approval/Launch, Product Lifecycle Planning and Development, R&D Business Systems design and delivery. Third Party Management, Women's Leadership Development. -
Alexandria Boehm
Richard and Rhoda Goldman Professor of Environmental Studies, Professor of Oceans and Senior Fellow at the Woods Institute for the Environment
BioI am interested in pathogens in the environment including their sources, fate, and transport in natural and engineered systems. I am interested in understanding of how pathogens are transmitted to humans through contact with water, feces, and contaminated surfaces. My research is focused on key problems in both developed and developing countries with the overarching goal of designing and testing novel interventions and technologies for reducing the burden of disease.
I am also interested broadly in coastal water quality where my work addresses the sources, transformation, transport, and ecology of biocolloids - specifically fecal indicator organisms, DNA, pathogens, and phytoplankton - as well as sources and fate of nitrogen. This knowledge is crucial to formulating new management policies and engineering practices that protect human and ecosystem health at the coastal margins. -
Alistair Boettiger
Associate Professor of Developmental Biology
Current Research and Scholarly InterestsMy lab focuses on investigating the role of three-dimensional genome organization in regulating gene expression and in shaping cell fate specification during development. We pursue this with advanced single-molecule imaging and transgenics.
-
Raya Bogdanova
Graduate, Medicine, Psychiatry and Behavioral Sciences
BioRaya Bogdanova joins the BRIDGE Lab as a Fulbright visiting student researcher from KU Leuven, where she is completing her Master of Medicine degree. With a long-standing interest in neurocognitive, developmental, and degenerative disorders, she has contributed to research in Alzheimer’s disease, Multiple Sclerosis, and gestational diabetes. Her current work focuses on ADHD-related brain signatures in children with RASopathies. Passionate about student wellbeing, Raya also lead the ADHD peer support network at KU Leuven, bridging her clinical interests with community engagement. Outside the lab, she enjoys swimming, hiking, and exploring art museums in new cities.
-
Matthew Bogyo
Professor of Pathology and of Microbiology and Immunology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur lab uses chemical, biochemical, and cell biological methods to study protease function in human disease. Projects include:
1) Design and synthesis of novel chemical probes for serine and cysteine hydrolases.
2) Understanding the role of hydrolases in bacterial pathogenesis and the human parasites, Plasmodium falciparum and Toxoplasma gondii.
3) Defining the specific functional roles of proteases during the process of tumorogenesis.
4) In vivo imaging of protease activity -
Bryan Bohman
Clinical Professor, Medicine - Primary Care and Population Health
BioBryan Bohman is Associate Chief Medical Officer for Workforce Health and Wellness. Additional roles include Clinical Professor of Medicine and of Anesthesiology, Co-Director of the Clinical Effectiveness Leadership Training (CELT) program and Senior Advisor to the WellMD Center.
Bryan trained at Stanford in internal medicine and anesthesiology. After two decades of clinical practice in community-based anesthesiology, he served as SHC's first elected Chief of Staff from 2008-2011.
As Chief of Staff, Dr. Bohman established Stanford’s wellness committee and subsequently shepherded the founding of its WellMD Center in 2015, serving as the Center’s interim Director until 2017. The Center’s aim is to advance faculty, trainee and care team wellbeing across Stanford Medicine while also serving as an international leader of scholarship in occupational wellbeing. Bryan also led the establishment in 2014 of the CELT program, which continues to serve as a driver of clinical quality improvement across Stanford Medicine.
Dr. Bohman’s primary areas of interest include occupational wellbeing, process improvement, and the reciprocal influences between quality improvement, healthcare system performance, and the occupational wellbeing of healthcare personnel. -
Brian Boitnott
Ph.D. Student in Biomedical Physics, admitted Autumn 2023
BioI am currently a Biomedical Physics PhD candidate in the Department of Radiology. In the two years prior to Stanford, I was at MIT Lincoln Laboratory, where I worked on remote sensing systems and was on the core team developing a laser-ultrasound system for medical imaging.
My interests revolve around health technology and perception. I started in neuroscience, studying attention and cognitive control, and now work on designing systems and algorithms for sensing and processing biomedical signals. My broader interests are at the intersection between emerging technology innovation, translation, and long-term innovation strategy.
